“…A long period, ranging from 10 to 40 years, was required in most of the previous clinical studies to trace a statistically significant number of intracranial tumors in infants and neonates [8,9,11,12,13,14,18,22,23,24,25,26,27,28,29]; several publications reported follow-up over a moderate period of 5–7 years [10,21]. Therefore, most of these studies were subject to diagnostic and prognostic biases stemming from the wide gap between the outdated tools initially used and the remarkable recent advances in neuroimaging procedures, neuroanesthesia, neurosurgical techniques, perioperative intensive care facilities and modern adjuvant chemotherapeutic regimens [30].…”